3/26
08:27 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
3/7
12:54 pm
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $150.00 price target on the stock, down previously from $185.00.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $150.00 price target on the stock, down previously from $185.00.
3/7
12:54 pm
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $150.00 price target on the stock, down previously from $185.00.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $150.00 price target on the stock, down previously from $185.00.
3/7
12:37 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
3/7
12:37 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/21
08:47 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $185.00 price target on the stock.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $185.00 price target on the stock.
2/11
05:23 am
nbix
Neurocrine initiated with a Hold at Deutsche Bank
Low
Report
Neurocrine initiated with a Hold at Deutsche Bank
2/11
05:23 am
nbix
Neurocrine initiated with a Hold at Deutsche Bank
Low
Report
Neurocrine initiated with a Hold at Deutsche Bank
2/10
08:53 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/10
08:53 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/7
03:07 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/7
03:07 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/7
02:00 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/7
02:00 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/7
01:55 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/7
10:11 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at William Blair.
2/7
10:11 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at William Blair.
2/7
08:28 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
2/7
07:22 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/7
07:22 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/4
08:04 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/4
08:04 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/30
06:14 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/8
10:00 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX